Hydrogel of Ketoconazole and PAMAM Dendrimers: Formulation and Antifungal Activity
暂无分享,去创建一个
Katarzyna Winnicka | Piotr Wieczorek | K. Winnicka | M. Wróblewska | P. Wieczorek | P. Sacha | E. Tryniszewska | Magdalena Wroblewska | Pawel Tomasz Sacha | Elzbieta Tryniszewska
[1] Analette I. Lopez,et al. Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers. , 2009, Molecular bioSystems.
[2] Xu Tongwen,et al. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. , 2007 .
[3] C. Nombela,et al. Inhibitory and morphological effects of several antifungal agents on three types of Candida albicans morphological mutants. , 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[4] J. Solecka,et al. Design of Antimicrobially Active Small Amphiphilic Peptide Dendrimers , 2009, Molecules.
[5] M. Şenel,et al. Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. , 2009, European journal of medicinal chemistry.
[6] H. Lennernäs,et al. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique. , 2003, British journal of clinical pharmacology.
[7] N. K. Jain,et al. Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam. , 2009, Molecular pharmaceutics.
[8] K. Viras,et al. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. , 2006, International journal of pharmaceutics.
[9] M. Borgers. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. , 1980, Reviews of infectious diseases.
[10] D. Nesseem. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. , 2001, Journal of pharmaceutical and biomedical analysis.
[11] I. Alberti,et al. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. , 2001, International journal of pharmaceutics.
[12] István Antal,et al. Aqueous solvent system for the solubilization of azole compounds. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] A. D'emanuele,et al. Crossing cellular barriers using dendrimer nanotechnologies. , 2006, Current opinion in pharmacology.
[14] Anil K Patri,et al. Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.
[15] Sonke Svenson,et al. Dendrimers as versatile platform in drug delivery applications. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[16] D. Tomalia. Dendrimer research. , 1991, Science.
[17] T. Xu,et al. Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study. , 2007, European journal of medicinal chemistry.
[18] C. Kauffman,et al. Use of azoles for systemic antifungal therapy. , 1997, Advances in pharmacology.
[19] M. T. Hampton. Atlas of Clinical Fungi , 1997 .
[20] J. Pemán,et al. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. , 2003, Diagnostic microbiology and infectious disease.
[21] J. Senger. Monsanto dioxin studies. , 1991, Science.
[22] M S Marriott,et al. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals. , 1980, Journal of general microbiology.
[23] A. Carlucci,et al. Study of In Vitro Drug Release and Percutaneous Absorption of Fluconazole from Topical Dosage Forms , 2010, AAPS PharmSciTech.
[24] T. Aoyagi,et al. Polymerization of benzalkonium chloride-type monomer and application to percutaneous drug absorption enhancer , 1990 .
[25] T. Xu,et al. Dendrimers as drug carriers: applications in different routes of drug administration. , 2008, Journal of pharmaceutical sciences.
[26] B. Ongpipattanakul,et al. Characterization of the permselective properties of excised human skin during iontophoresis. , 1987, Journal of pharmaceutical sciences.
[27] T. Aoyagi,et al. Polymeric percutaneous drug penetration enhancer: Synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group , 1997 .
[28] Venkata Vamsi K Venuganti,et al. Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration. , 2009, Journal of pharmaceutical sciences.
[29] Lajos P. Balogh,et al. Dendrimer−Silver Complexes and Nanocomposites as Antimicrobial Agents , 2001 .
[30] Z. Knežević-Jugović,et al. Microbial polysaccharides and their derivatives as current and prospective pharmaceuticals. , 2008, Current pharmaceutical design.
[31] Omathanu Perumal,et al. Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. , 2008, International journal of pharmaceutics.
[32] K. Winnicka,et al. Poly(amidoamine) dendrimers increase antifungal activity of clotrimazole. , 2011, Biological & pharmaceutical bulletin.
[33] D. Tomalia. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry , 2005 .
[34] S. Milewski,et al. Novel dendrimeric lipopeptides with antifungal activity. , 2012, Bioorganic & medicinal chemistry letters.
[35] Mark Bradley,et al. Antibacterial single-bead screening , 2003 .
[36] Xiaomin Wang,et al. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. , 2007, Journal of pharmaceutical sciences.
[37] Clinical,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .